• Home
  • 18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy.

18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy.

Author List
Diwanji D, Ray K, Hylton N
Publication
Radiology. Imaging cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/228782098
Publication Year
2021
PubMed ID
34533375
Publication Title
Diwanji D, Ray K, Hylton N. 18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy. Radiol Imaging Cancer. 2021 09; 3(5):e219021.